Skip to main content

Grace Wang, Week 1: Settling In

     I started work on June 4, just a week after spring term exams. Thankfully I didn't have much trouble finding my lab's building because I had visited it in fall term for an interview. For the duration of my lab, I start work at 9:30 AM and end at 5 PM.
     "We're going to the mouse room to injure some mice," my postdoc voiced, walking me to said mouse room. It was only my first day in lab; talk about hitting the ground running. After selecting two boxes of mice in a room lined with shelves of them, my postdoc Dr. Elisia Tichy, or Elisia as we call her, explained to me that she would injure the muscles of the mice. To do so, she anesthetized them and injured their target muscles using injections of notexin, an enzyme found in snake venom. The notexin injuries would cause the muscle stem cells of the mice to activate and divide in abundance. Next week, we will collect their muscle stem cells and analyze them using telomere assays and microscopy. This 6-week-long project is actually in its 5th week of experimentation, so next week will be the final week that Elisia collects data before euthanizing the mice (my lab prefers the term euthanizing over sacrificing/killing). Afterwards, we will examine their skeletal muscles and Elisia will teach me a new technique called tissue histology. While the stench of mice isn't the most pleasant, visiting the mouse room has nonetheless been one of the highlights of my week.
     I also reviewed micropipetting, DNA isolation, PCR, and gel electrophoresis with my lab's grad-student-to-be, David. David will be leaving the lab around the same time I'm leaving because he will take a break before his graduate program at Penn starts. I realized I had forgotten a lot about these techniques from bio class (I wish I had reviewed them before starting in lab!), but David gave the two undergraduate students and me a comprehensive review of them. We performed PCR for the DNA of Pax7GFP (mice mutated in Pax7 gene which have their DNA tagged with green fluorescent proteins) and mTR mice (mutated for the gene which regulates telomerase activity). We'll run the gels and analyze them next week.
     I've been given a variety of tasks to do so far, something I've been pleased about. For instance, I have also been using an imaging software to analyze the areas of muscle fibers. It's a bit repetitive admittedly, but it's nice to participate in both experimentation and analysis in the lab. The images I am analyzing are for our lab's new project, which is in collaboration with Penn's bioengineering department and the nearby medical center. We essentially aim to promote the healing of neurons in conjunction with skeletal muscles in rats. If the project is successful, it has the potential to provide medical aid to military soldiers and veterans; the successful regeneration of neurons and muscle can repair wounds from explosions.
     Overall, my first week has gone really well. Everyone in the lab is really knowledgeable and willing to help. I'll start analyzing data next week, and my PI says she will assign me to a new sub-project soon. Since Dr. Peretz advised us EXP students to bring donuts to our lab in the 2nd week, I figured that next week would also be a good time to celebrate turning 17. My experience has been very educational so far; I'm really looking forward to learning new techniques and contributing to the ongoing research in the next seven weeks.

Comments

Post a Comment

Popular posts from this blog

Kylie Heering, Week 2 at the Goldstein Lab

We started off our week with a congratulatory acai bowl trip to celebrate Preston’s acceptance into a training grant program. Acai bowls in California top Playa Bowls (no question about it). From what I can tell, its a pretty huge honor to be recognized by this grant, but he’s really humble about it. On Monday, Preston and I decided that testing antibodies that have never been tested on prostate epithelial cells before would be a good objective for my first Western blot on my own. We needed to probe for ASCT2, a glutamine transporter, and GLS in order to determine if their corresponding antibodies are functional. Antibodies are crucial for Western blots because they bind to the protein of interest (POI), allowing for us to qualify its expression after imaging. As such, Preston wanted to make sure they worked by probing for ASCT2 and GLS on three different cell lines. Cell lines are commercially purchased human cells that have been immortalized (modified to grow indefinitely) by telome...

Alan - First Week at UCSF

Hi Everyone! After arriving in San Francisco last Sunday, I spent this past week settling into the downtown Berkeley apartment that I’ll be sharing with Rohit for the next couple of months, as well as learning my way around the Roy lab at UCSF. First day at the lab was really exciting. Here are a couple pictures of the Mission Bay campus, which was completed just a few years ago. Everything is super new and modern, and there’s still construction for other buildings going on around the campus. Most of the people who work at the Mission Bay campus are either professional researchers or doctors/nurses for the nearby hospital. The graduate students take most of their classes at the original Parnassus campus (where Maya is). I work in Byers Hall, which is connected to Genentech Hall and a short walk down the block from the shuttle stop. There are three other volunteers working for the Roy lab this summer – Kimmai, David, and Pujita, who are all undergrad college students...

Jaewon Oh - Week 7 and 8

Finally done here with my experience and I wish I had more time keep researching so that I have something a little more "finalised" to present. But I guess that's what past EXP kids meant when they said that 8 weeks of research is not enough and I'll have to work with what I've got. To solve the problem of not having enough data points, we used the online TCGA database for raw data that would be used to calculate mutation rates. Mutation rates were calculated through an R coding script that Dr. Cannataro had made. Because the mutation rates were tumor specific, we had to change the proportions that were obtained from the IARC database using data from another database called cBioPortal. Basically we had to multiply the number of times a certain variant was seen in the IARC database by the percentage of tumors that have a tp53 mutation, because our mutation rates are calculated across all tumors in specific cancers (confusing, I know). After graphing the mutatio...